Skip to content

What is Vaccinium macrocarpon? — PlantSage

0Vaccinium macrocarpon·What is5 answers
0Section · 00

What is Vaccinium macrocarpon

— Short, snippet-friendly answers to the most-asked questions about Vaccinium macrocarpon (Vaccinium macrocarpon). For the full profile with citations, open the main page.

What is Vaccinium macrocarpon?

Vaccinium macrocarpon, commonly known as the cranberry, is a subshrub or small shrub native to northeastern and north-central regions of North America, including states like Connecticut, Delaware, Illinois, Indiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Hampshi… Vaccinium macrocarpon (Latin: Vaccinium macrocarpon) is a medicinal plant catalogued in PlantSage.

What is Vaccinium macrocarpon used for?

Vaccinium macrocarpon is most often used to support immune support. Each claim is rated by evidence strength - see the full profile for citations.

Is Vaccinium macrocarpon safe?

Vaccinium macrocarpon is generally considered safe when used at traditional doses. Always consult a clinician before using any herbal preparation — especially during pregnancy, breastfeeding, while on medication, or for children.

Where does Vaccinium macrocarpon grow?

Vaccinium macrocarpon is a member native to CNT, DEL, WDC, ILL, INI, and MAI. Vaccinium macrocarpon thrives in full to partial sun and prefers moist to wet soil that is light (sandy) or medium.

Can I grow Vaccinium macrocarpon at home?

Vaccinium macrocarpon grows best in full sun, partial sun/shade light and moist, wet water. Detailed sowing, propagation, and care notes are on the full profile.

Full profile Safety by audience →Preparation forms →Edible plants index →Browse catalogue →
❦❦❦❦
Endpaper · archive updates

Get archive updates

Occasional email when substantial new content lands — plant profiles, seasonal growing notes, folk-remedy additions. Free, no tracking, unsubscribe anytime.

Newsletter returning soon.
We are rebuilding the update list around a lightweight editorial workflow. New dispatches will resume after the next content review cycle.